No Data
No Data
No Data
No Data
No Data
NH HEALTH: INSIDE INFORMATION DELAY IN PUBLICATION OF THE 2023 ANNUAL RESULTS;POSTPONEMENT OF BOARD MEETING;AND SUSPENSION OF TRADING
Futu NewsMar 28 10:52 ET · Announcements
Institutional Owners May Consider Drastic Measures as New Horizon Health Limited's (HKG:6606) Recent HK$651m Drop Adds to Long-term Losses
Key Insights Institutions' substantial holdings in New Horizon Health implies that they have significant influence over the company's share price 51% of the business is held by the top 9 shareholder
Simply Wall StMar 18 20:02 ET
Novartis Health (06606.HK) plans to hold a board meeting on March 28 to consider and approve the annual results
Glonghui, March 18, 丨 Novartis Health (06606.HK) announced that the board of directors meeting will be held on March 28, 2024 (Thursday) to consider and approve (among other things) the results and announcements of the Company, its subsidiaries and consolidated affiliated entities for the year ended 31 December 2023, and to deal with other matters.
Gelonghui FinanceMar 18 10:43 ET
NH HEALTH: NOTICE OF BOARD MEETING
Futu NewsMar 18 10:41 ET · Announcements
Is It Too Late To Consider Buying New Horizon Health Limited (HKG:6606)?
New Horizon Health Limited (HKG:6606), is not the largest company out there, but it saw a decent share price growth of 14% on the SEHK over the last few months. The recent rally in share prices
Simply Wall StFeb 12 18:17 ET
Changes in Hong Kong stocks | Minimally Invasive Brain Science (02172) rose more than 5%, leading medical device stock institutions optimistic about the future prospects of overseas expansion of domestic medical devices
The increase in medical device stocks increased in the afternoon. As of press release, Minimally Invasive Brain Science (02172) rose 6.46% to HK$9.4; Chunli Healthcare (01858) rose 4.61% to HK$9.31; Haohai Biotech (06826) rose 3.71% to HK$34.95; and Novi Health (06606) rose 2.35% to HK$18.28.
Zhitong FinanceFeb 8 01:42 ET
No Data
No Data